.css-1xsl8rf{width:100%;display:-webkit-box;display:-webkit-flex;display:-ms-flexbox;display:flex;-webkit-align-items:center;-webkit-box-align:center;-ms-flex-align:center;align-items:center;position:relative;overflow:hidden;background:var(--alert-bg);-webkit-padding-start:var(--chakra-space-4);padding-inline-start:var(--chakra-space-4);-webkit-padding-end:var(--chakra-space-4);padding-inline-end:var(--chakra-space-4);padding-top:var(--chakra-space-1);padding-bottom:var(--chakra-space-1);--alert-fg:var(--chakra-colors-orange-600);--alert-bg:var(--chakra-colors-orange-100);font-weight:var(--chakra-fontWeights-semibold);padding-left:var(--chakra-space-4);}.chakra-ui-dark .css-1xsl8rf:not([data-theme]),[data-theme=dark] .css-1xsl8rf:not([data-theme]),.css-1xsl8rf[data-theme=dark]{--alert-fg:var(--chakra-colors-orange-200);--alert-bg:rgba(251, 211, 141, 0.16);}@media screen and (min-width: 48em){.css-1xsl8rf{padding-left:var(--chakra-space-8);}}Bitte aktivieren Sie Javascript um alle Funktionen nutzen zu können und ihre Nutzererfahrung zu verbessern.

Programm Personen

DE

Poster zum Thema "Blood Safety"

PS-2-18

2 Years of experience in HEV Screening of plasma donors

Viktoria Dienst (Leipzig/ DE)

PS-2-19

Impact of hepatitis E notification on donor return

PD Dr. Franz F. Wagner (Springe/ DE)

PS-2-20

Evaluation of a new PCR-based CMV assay for blood donor screening

Dr. Marijke Weber-Schehl (Wiesentheid/ DE)

PS-2-21

Routine blood donor screening on a new NAT platform

Dr. Marijke Weber-Schehl (Wiesentheid/ DE)

PS-2-22

Reduction in the initial reactive rate by a new HBsAg assay version

Prof. Dr. Jens Dreier (Bad Oeynhausen/ DE)

- v1.20.0
- © Conventus Congressmanagement & Marketing GmbH
- Impressum
- Datenschutz